ELOX SEC Filings | SEC Document SEARCH
Back to Search
Eloxx Pharmaceuticals, Inc. (ELOX)
Ticker: ELOX
CIK: 0001035354
21
Filings Found (Last 1 Year)
Filter Filings
All
S-1
2026. 9. 11.
Eloxx Pharmaceuticals, Inc. (ELOX) (CIK 0001035354)
Registration statement
S-1
Open Filing
8-K
2026. 8. 11.
Eloxx Pharmaceuticals, Inc. (ELOX) (CIK 0001035354)
Current report
8-K
Open Filing
10-Q
2026. 6. 30.
Eloxx Pharmaceuticals, Inc. (ELOX) (CIK 0001035354)
Quarterly report
10-Q
Open Filing
4
2026. 6. 10.
Domicilium Real Estate Fund III LP (CIK 0001945896)
Insider trading report
Open Filing
4
2026. 6. 8.
Webster Stephen W (CIK 0001438421)
Insider trading report
4
Open Filing
4
2026. 6. 8.
Walts Alan Edmund (CIK 0001853544)
Insider trading report
4
Open Filing
4
2026. 6. 10.
Aggarwal Sumit (CIK 0001854362)
Insider trading report
4
Open Filing
4
2026. 6. 8.
Kjellson Nina S (CIK 0001381980)
Insider trading report
4
Open Filing
4
2026. 6. 8.
Rubin Steven D (CIK 0001381874)
Insider trading report
4
Open Filing
4
2026. 5. 27.
Domicilium Real Estate Fund III LP (CIK 0001945896)
Insider trading report
Open Filing
S-1/A
2026. 6. 4.
Eloxx Pharmaceuticals, Inc. (ELOX) (CIK 0001035354)
S-1/A
S-1/A
Open Filing
S-1/A
2026. 6. 1.
Eloxx Pharmaceuticals, Inc. (ELOX) (CIK 0001035354)
S-1/A
S-1/A
Open Filing
8-K
2026. 5. 27.
Eloxx Pharmaceuticals, Inc. (ELOX) (CIK 0001035354)
Current report
8-K
Open Filing
4
2026. 5. 27.
Coastlands Capital LP (CIK 0002068530)
Insider trading report
OWNERSHIP DOCUMENT
Open Filing
4
2025. 9. 19.
Rubin Steven D (CIK 0001381874)
Insider trading report
4
Open Filing
4
2022. 2. 6.
Aggarwal Sumit (CIK 0001854362)
Insider trading report
4
Open Filing
4
2025. 9. 19.
Walts Alan Edmund (CIK 0001853544)
Insider trading report
4
Open Filing
S-1
2026. 5. 7.
Eloxx Pharmaceuticals, Inc. (ELOX) (CIK 0001035354)
Registration statement
S-1
Open Filing
10-Q
2026. 3. 31.
Eloxx Pharmaceuticals, Inc. (ELOX) (CIK 0001035354)
Quarterly report
10-Q
Open Filing
8-K
2026. 4. 28.
Eloxx Pharmaceuticals, Inc. (ELOX) (CIK 0001035354)
Current report
8-K
Open Filing
10-K
2025. 12. 31.
Eloxx Pharmaceuticals, Inc. (CIK 0001035354)
Annual report
10-K
Open Filing
Previous
Page 7 of 2
Next